Associations of severe liver diseases with cataract using data from UK Biobank: a prospective cohort studyResearch in context

Associations of severe liver diseases with cataract using data from UK Biobank: a prospective cohort studyResearch in context

Summary: Background: Liver disease is linked to series of extrahepatic multisystem manifestations. However, little is known about the associations between liver and eye diseases, especially cataract, the global leading cause of blindness. We aimed to investigate whether severe liver diseases, inclu...

Full description

Bibliographic Details
Main Authors:	Chao Chen, Ling Wei, Wenwen He, Ye Zhang, Jia Xiao, Yi Lu, Fei Wang, Xiangjia Zhu
Format:	Article
Language:	English
Published:	Elsevier 2024-02-01
Series:	EClinicalMedicine
Subjects:	Cataract Non-alcoholic fatty liver disease Alcoholic liver disease Viral hepatitis Liver fibrosis Cirrhosis
Online Access:	http://www.sciencedirect.com/science/article/pii/S2589537024000038

Similar Items

Liver diseases: Perspective from the Philippines
by: Eric David Ornos, et al.
Published: (2023-05-01)

Alcoholic liver disease. An update
by: Nahum Méndez-Sánchez, et al.
Published: (2005-01-01)

Non-invasive Diagnostics of Liver Fibrosis
by: Mihaylov R., et al.
Published: (2017-05-01)

Changes in indicators of fibrosis in patients with alcoholic liver cirrhosis associated with non-alcoholic fatty liver disease depending on the stage of cirrhosis
by: N. R. Matkovska, et al.
Published: (2020-06-01)

Role of liver transplantation in severe alcoholic hepatitis
by: Ravi Daswani, et al.
Published: (2018-03-01)

U-shaped relationship between urea level and hepatic decompensation in chronic liver diseases
by: Huapeng Lin, et al.
Published: (2022-01-01)

Noninvasive Tests (NITs) for Hepatic Fibrosis in Fatty Liver Syndrome
by: Ma Ai Thanda Han
Published: (2020-09-01)

Non-invasive diagnosis of liver steatosis: ready for primetime?
by: Nicolas Goossens
Published: (2019-07-01)

Association Between Low Muscle Mass and Non-alcoholic Fatty Liver Disease Diagnosed Using Ultrasonography, Magnetic Resonance Imaging Derived Proton Density Fat Fraction, and Comprehensive NAFLD Score in Korea
by: Hun Ju Lee, et al.
Published: (2021-11-01)

Features of the State of Internal Organs and the Structure of Comorbidity in Deceased Persons With Alcoholic Liver Cirrhosis, Non-alcoholic Fatty Liver Disease at the Cirrhosis Stage and Alcoholic Liver Cirrhosis Associated With Insulin Resistance and Obesity
by: N. Matkovska
Published: (2020-06-01)

Characteristics of intestinal bacteria with fatty liver diseases and cirrhosis
by: Guohong-Liu, et al.
Published: (2019-11-01)

CHANGES IN FIBROSIS UNDER THE INFLUENCE OF TREATMENT OF PATIENTS WITH ALCOHOLIC CIRRHOSIS OF THE LIVER IN COMBINATION WITH OBESITY USING ADEMETHYANINIUM AND ARGININE GLUTAMATE
by: N.R. Matkovska
Published: (2020-11-01)

The effect of moderate alcohol drinking in nonalcoholic fatty liver disease
by: Jong Hwa Choi, et al.
Published: (2020-10-01)

Association of Cholecystectomy With Liver Fibrosis and Cirrhosis Among Adults in the USA: A Population-Based Propensity Score-Matched Study
by: Zhi-Qin Xie, et al.
Published: (2021-11-01)

Diet and Risk of Non-Alcoholic Fatty Liver Disease, Cirrhosis, and Liver Cancer: A Large Prospective Cohort Study in UK Biobank
by: Wen Guo, et al.
Published: (2022-12-01)

Liver Disease: Induction, Progression, Immunological Mechanisms, and Therapeutic Interventions
by: Sarah Y. Neshat, et al.
Published: (2021-06-01)

The Enhanced Liver Fibrosis test is associated with liver-related outcomes in postmenopausal women with risk factors for liver disease
by: Paul M. Trembling, et al.
Published: (2020-04-01)

Causes of death in patients with Non-alcoholic Fatty Liver Disease (NAFLD), alcoholic liver disease and chronic viral Hepatitis B and C
by: Pegah Golabi, et al.
Published: (2022-01-01)

MicroRNAs in non-alcoholic fatty liver disease: Progress and perspectives
by: Mette Yde Hochreuter, et al.
Published: (2022-11-01)

Diabetes mellitus and chronic liver diseases. Part 1: general mechanisms of etiology and pathogenesis
by: Z A Kalmykova, et al.
Published: (2019-10-01)

Ambiguous Pathogenic Roles of Macrophages in Alcohol-Associated Liver Diseases
by: Ait Ahmed Y, et al.
Published: (2023-09-01)

Clinical Characteristics, Etiology, and Prognostic Scores in Patients with Acute Decompensated Liver Cirrhosis
by: Hoor Al Kaabi, et al.
Published: (2023-09-01)

Diabetes mellitus and chronic liver diseases. Literature review (part 2): treatment features
by: Z A Kalmykova, et al.
Published: (2019-12-01)

Risk of Cirrhosis in Patients with Non-alcoholic Fatty Liver Disease and Previous Viral Hepatitis B
by: S. N. Batskikh, et al.
Published: (2020-09-01)

Management Strategies for Liver Fibrosis
by: Alejandra Altamirano-Barrera, et al.
Published: (2017-01-01)

Liver Fibrosis and MAFLD: From Molecular Aspects to Novel Pharmacological Strategies
by: Weiyi Qu, et al.
Published: (2021-10-01)

Establishment of Novel Mouse Model of Dietary NASH Rapidly Progressing into Liver Cirrhosis and Tumors
by: Qianqian Zheng, et al.
Published: (2023-07-01)

Genetic effects of iron levels on liver injury and risk of liver diseases: A two-sample Mendelian randomization analysis
by: Kai Wang, et al.
Published: (2022-09-01)

Liquid Biopsy for the Diagnosis of Viral Hepatitis, Fatty Liver Steatosis, and Alcoholic Liver Diseases
by: Ciniso Sylvester Shabangu, et al.
Published: (2020-05-01)

Evaluation and management of extrahepatic manifestations of nonalcoholic fatty liver disease
by: Karn Wijarnpreecha, et al.
Published: (2021-04-01)

Imbalance of mitochondrial fusion in peripheral blood mononuclear cells is associated with liver fibrosis in patients with metabolic dysfunction-associated steatohepatitis
by: Thanaput Kunlayawutipong, et al.
Published: (2024-03-01)

Crosstalk between Oxidative Stress and Inflammatory Liver Injury in the Pathogenesis of Alcoholic Liver Disease
by: Yoon Mee Yang, et al.
Published: (2022-01-01)

Cost-effectiveness of non-invasive methods for assessment and monitoring of liver fibrosis and cirrhosis in patients with chronic liver disease: systematic review and economic evaluation
by: Catriona Crossan, et al.
Published: (2015-01-01)

Old age as a risk factor for liver diseases: Modern therapeutic approaches
by: Milena Georgieva, et al.
Published: (2023-12-01)

Effect of Non-alcoholic Fatty Liver Disease on the Risk of Synchronous Liver Metastasis: Analysis of 451 Consecutive Patients of Newly Diagnosed Colorectal Cancer
by: Yan Lv, et al.
Published: (2020-02-01)

Liver Stiffness-Based Risk Prediction Model for Hepatocellular Carcinoma in Patients with Nonalcoholic Fatty Liver Disease
by: Jae Seung Lee, et al.
Published: (2021-09-01)

Principles of treatment of different forms of alcoholic liver disease: A review
by: Karina L. Raikhelson, et al.
Published: (2023-03-01)

Liver diseases in the general population – the importance of active screening
by: Mária Beloviová, et al.
Published: (2023-09-01)

Effects of one-year supplementation with Phyllanthus niruri on fibrosis score and metabolic markers in patients with non-alcoholic fatty liver disease: A randomized, double-blind, placebo-controlled trial
by: Muhammad Radzi Abu Hassan, et al.
Published: (2023-06-01)

Comparison of Transient Elastography and Liver Biopsy in Assessing Fibrosis in Patients with Nonalcoholic Fatty Liver Disease
by: Gaurav Bachhav, et al.
Published: (2021-05-01)